Skip to content
OpenCapital
Get started

NewAmsterdam Pharma Company NAMS Enterprise value

Enterprise value at other companies

Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Amgen logo
AmgenAMGN
$246.43B+9.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$2.69B+37.1%

Other financials

Income statement

See full
Revenue$3.0M+2.1%
Operating income-$58.4M+15.2%
Net income-$48.4M-22.6%
EPS (diluted)-$0.40-17.6%

Balance sheet

See full
Cash & equivalents$457.6M-38.9%
Total debt$23.0K-94.1%
Total equity$665.2M-14.4%
Total assets$732.6M-10.5%

Cash flow

See full
Operating cash flow-$30.6M+16.1%
CapEx$38.0K+138%
Free cash flow-$30.6M+16.0%

Valuation

See full
Market cap$3.67B+63.7%

Profitability

See full
Operating margin-953.6%-3,536pp
Net margin-942.8%-3,477pp
FCF margin-630.1%-6,324pp

Returns & leverage

See full
Return on equity-29.5%-1.8pp
Current ratio9.8×-10.2×

Where this comes from

Calculated from NewAmsterdam Pharma Company’s reported figures.

$3.7Bmarket cap+$23.0Ktotal debt−$457.6Mcash and equivalents=$3.22B

The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NewAmsterdam Pharma Company's enterprise value?
NewAmsterdam Pharma Company (NAMS) reported enterprise value of $3.22B in Q1 2026.
How has NewAmsterdam Pharma Company's enterprise value changed year-over-year?
NewAmsterdam Pharma Company's enterprise value increased by 114.9% year-over-year, from $1.5B to $3.22B.
What is the long-term trend for NewAmsterdam Pharma Company's enterprise value?
Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's enterprise value has grown at a 89.4% compound annual growth rate (CAGR), from $513.24M to $3.49B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.